• HUMAN ISLETS FOR RESEARCH-We currently supply human islets to both the academic and corporate communities for their research related to diabetes. We pride ourselves on providing the highest quality islets, which we have been able to produce by using our proprietary media (PIM-Prodo Islet Media)

  • PRODO ISLET MEDIA (PIM)™- Our media is a cGMP product and has been designed to increase the viability and purity of the cells, from the initial recovery to the stage where the islets are ready for study and experiments. Our media is capable of long-term culturing, of up to 21 days, without loss of purity and viability.

  • OUR SERVICES-Prodo Labs is capable of performing many services on a contract basis. Some of these services include performing assays, animal isolations and islet testing.

  • RESEARCH-Working in conjunction with the Scharp-Lacy Research Institute, Prodo Labs is committed to performing research which could lead to a cure for diabetes. Led by Dr. David Scharp, MD, our company continues to break new ground in battling this debilitating disease.

Our Partners

Prodo Labs is currently working with the following international partners for distribution of our islets and media:

For distribution in Japan, please contact:
ontarget
On Target Co., Ltd.
Oomori Station Box 6F,
2-1-2 Sanno, Ota-ku, Tokyo 143-0023, Japan
TEL: +81-(0)3-5709-7588
FAX: +81-(0)50-3737-4412
Email: info@ontarget-ddss.co.jp
www.ontarget-ddss.co.jp

Research and Not For Profit Partners

Scharp-Lacy Research Institute
David Scharp, MD Chairman
32A Mauchly
Irvine, CA 92618
949-727-1972
www.scharplacy.org